GlassScriptPhysician profile
Melissa Keul
NPI 1104208198
$3,246.29
in general payments reported to CMS, 2019-2025
12 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $445 · 2022: $328 · 2023: $689 · 2024: $667 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,473.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,152.02 | 2021-2025 | Wegovy, Saxenda |
| Medtronic, INC. | $741.14 | 2023-2025 | Signia, Sonicision, Ligasure |
| W. L. Gore & Associates, INC. | $490.11 | 2022-2025 | Seamguard, Gore Synecor Biomaterial, Seamguard Staple Line Reinforcement |
| Lilly USA, LLC | $403.48 | 2022-2025 | Zepbound, Mounjaro |
| Madrigal Pharmaceuticals | $277.27 | 2025 | Rezdiffra |
| Cequr Corporation | $46.82 | 2023 | Cequr Simplicity |
| Amgen INC. | $41.93 | 2024 | Evenity, Prolia |
| Abbvie INC. | $22.29 | 2021 | |
| Xeris Pharmaceuticals, INC. | $19.20 | 2023 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $18.19 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Rhythm Pharmaceuticals, INC. | $17.78 | 2023 | Imcivree |
| Abbott Laboratories | $16.06 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Keul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.